Efficient Development of Platform Cell Lines Using CRISPR-Cas9 1 and Transcriptomics Analysis
Kwon, A. T.-J.; Mohri, K.; Takizawa, S.; Arakawa, T.; Takahashi, M.; Kaczkowski, B.; Furuno, M.; Suzuki, H.; Tagami, S.; Mukai, H.; Arner, E.
Show abstract
Antibody-drug conjugates offers many advantages as a drug delivery platform that allows for highly specific targeting of cell types and genes. Ideally, testing the efficacy of these systems requires two cell types to be different only in the gene targeted by the drug, with the rest of the cellular machinery unchanged, in order to minimize other potential differences from obscuring the effects of the drug. In this study, we created multiple variants of U87MG cells with targeted mutation in the TP53 gene using the CRISPR-Cas9 system, and determined that their major transcriptional differences stem from the loss of p53 function. Using the transcriptome data, we predicted which mutant clones would have less divergent phenotypes from the wild type and thereby serve as the best candidates to be used as drug delivery testing platforms. Further in vitro and in vivo assays of cell morphology, proliferation rate and target antigen-mediated uptake supported our predictions. Based on the combined analysis results, we successfully selected the best qualifying mutant clone. This study serves as proof-of-principle of the approach and paves the way for extending to additional cell types and target genes.
Matching journals
The top 9 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Tracing production instability in a clonally-derived CHO cell line using single cell transcriptomics 94%
- Expanding the Chinese hamster ovary cell long non-coding RNA transcriptome using RNASeq 91%
- Increasing cell-free gene expression yields from linear templates in Escherichia coli and Vibrio natriegens extracts by using DNA-binding proteins 91%
Similar papers in this journal
- Parallel CRISPR-Cas9 screens clarify impacts of p53 on screen performance 95%
- Complementary CRISPR screen highlights the contrasting role of membrane-bound and soluble ICAM-1 in regulating antigen specific tumor cell killing by cytotoxic T cells 95%
- Extracellular ATP drives pancreatic cancer cell invasion via purinergic receptor-integrin interactions 94%
Similar papers in this journal
- Novel allosteric mechanism of dual p53/MDM2 and p53/MDM4 inhibition by a small molecule 93%
- A Transient Metabolic State In Melanoma Persister Cells Mediated By Chemotherapeutic Treatments 92%
- Branched Oncolytic Peptides Target HSPGs, Inhibit Metastasis, and Trigger the Release of Molecular Determinants of Immunogenic Cell Death in Pancreatic Cancer. 92%
Similar papers in this journal
- A Non-genetic Mechanism for Chemoresistance in Lung Cancer: The Role of Integrin β4/Paxillin Axis 95%
- Sensitization of FOLFOX-resistant colorectal cancer cells via the modulation of a novel pathway involving protein phosphatase 2A 93%
- C9orf72 poly(PR) mediated neurodegeneration is associated with nucleolar stress 93%
Similar papers in this journal
- The CoREST complex is a therapeutic vulnerability in malignant peripheral nerve sheath tumors 94%
- Transcriptomic analysis of melanoma cells reveals an association of α-synuclein with regulation of the inflammatory response. 94%
- Noncannonical functions of Ku may underlie essentiality in human cells 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.